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for the intention to use the EMR. For nurses this attribute was followed by support 
from supervisor, presence of performance feedback from the EMR and presence o 
f decisions support. While for physicians this ordering differed since presence of 
decision support was relatively more important than performance feedback and 
support from the supervisor. ConClusions: Considering the prominent wish of all 
the intended users for a flexible interface, currently used EMRs only partially comply 
with the needs of the users, indicating the need for closer incorporation of user 
needs during development stages of EMRs. The differences in priorities amongst 
nurses and physicians show that different users have different needs during the 
implementation of innovations. Hospital management may use this information to 
design implementation trajectories to fit the needs of various user groups.
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objeCtives: To describe the current status of Pharmacoeconomic (PE) research 
in China from Jan 2002 through June 2013. Methods: We conducted a review of 
pharmacoeconomic studies performed in China during Jan 2002 to June 2013. Using 
the Wanfang Chinese Database, we identified a total of 1338 articles. Keywords used 
are ‘Pharmacoeconomics’ or ‘Cost-Effectiveness Analysis’ or ‘Cost-Benefit Analysis’ 
or ‘Cost-Utility Analysis’ or ‘Cost’ or ‘Cost Study’ or ‘Economics Analysis’ all following 
by ‘(Healthcare and Medical Care)’ to exclude animal and other studies. Through a 
manual review, we excluded another 52 articles that did not align with study objec-
tives. Article types selected are Journals, Academic Essays and Conference Essays. 
Descriptive analyses were performed to identify current trends, including number 
of articles by year, type of studies, and type of studies by year. Results: A total of 
1286 articles were conducted in China from 2002 to 2013. In general, the number of 
articles per year has been on the rise since 2002and appears to approach a steady 
state after 2007. Numbers of articles by year are 91 in 2002, 84 in 2003, 107 in 2004, 
110 in 2005, 136 in 2006, 132 in 2007, 121 in 2008, 120 in 2009, 130 in 2010, 116 in 2011, 
112 in 2012 and 27 during first half of 2013. The most common type of studies found 
were economic analyses (n= 908/1286), of which cost-benefit analyses (n= 395) were 
most commonly conducted. Two other common research types included treatment 
use (n= 48) and application of PE (n= 146), namely the role of PE to help determine 
price and inform health care management decisions. ConClusions: The devel-
opment of Pharmacoeconomic research in China has been on a steady rise since 
2002 with most output focused on economic modeling, followed by application of 
PE and treatment use.
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objeCtives: Economic evaluations of interventions in the hospital setting often 
rely on the estimated long-term impact on patient survival. Estimates of mortality 
rates and long-term outcomes among patients discharged alive from the inten-
sive care unit (ICU) are lacking from lower and middle-income countries. This 
study aimed to assess the long-term survival, life expectancy (LE) and the quality-
adjusted life expectancy (QALE) amongst post-ICU patients in a middle-income 
country. Methods: In this retrospective cohort study, data from a regional tertiary 
hospital in northeast Thailand and the regional death registry were linked and used 
to assess patient survival time after ICU discharge. Adult ICU patients aged at least 
15 years who had been discharged alive from an ICU between 1anuary 1, 2004 and 
December 31, 2005 were included in the study, and the death registry was used to 
determine deaths occurring in this cohort up to December 31, 2010. These data 
were used in conjunction with standard mortality life tables to estimate annual 
mortality and LE. Results: A total of 10,321 ICU patients were included in this 
analysis; 3,251 patients (31.5%) died during ICU admission. Of 7,070 patients dis-
charged alive, 2,527 (35.7%) were known to have died within the five-year follow-up 
period, a mortality rate 2.5 times higher than that in the Thai general population 
(age- and sex-matched). The mean LE was estimated as 18.3 years compared with 
25.2 years in the general population. Given the range of the Health Related Quality 
of Life (HRQOL) from the published literature, the mean QALE of post-ICU patients 
would range from 10.2 to 16.1. ConClusions: Post-ICU patients experienced much 
higher rates of mortality than members of the general population over the five-year 
follow-up period, particularly in the first year after discharge. Further work assess-
ing HRQOL in both post-ICU patients and in the general population in developing 
countries is needed.
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Joint commission (JCI) International Patient centered standards-2011 promotes 
improvements in patient safety(ISPG) & Medication Management Use (MMU). 
objeCtives: To investigate historical changes of patient-safety approach in Saudi 
Arabia, create comparison baseline for future studies. Methods: Cross-sectional 
2003 survey sent to pharmacy managers of 127 hospitals of Ministry of Health(MOH); 
67.7% responded; data of 63.7% hospitals were valid for analysis. 19 hospitals were 
chosen deliberately according to their level of development, their data was tested 
against selected criteria. Due to limitations of data; only 2 criteria were selected: 
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objeCtives: Policy decision makers require accurate forecasts of the financial 
implications of funding a new drug. They may also wish to influence adoption to 
ensure the most cost-effective pattern of care. The seminal theory regarding the 
adoption of innovations was published by Rogers in 1962; but there are several 
reasons why health care may be a special case. This paper assesses the applicabil-
ity of Rogers’s theory to the adoption of new drugs, and identifies how it could 
be extended using economic theories of information. Methods: The empirical 
literature on drug adoption was reviewed to determine the consistency of findings 
with Rogers’s theory and the economic theories of information. Results: Overall 
74 empirical studies were reviewed. Clinicians consider a broad range of attributes 
when adopting a new drug, with their relative importance dependent on the patient 
and therapeutic area. Consistent with Rogers’s theory, interpersonal communication 
channels are the most important information source, with clinicians, especially GPs, 
more likely to rely on advice from specialists or pharmaceutical representatives than 
peer-reviewed publications. Moreover, clinicians are influenced by ‘norm’ prescrib-
ing behaviour. These findings can be further explained using economic theories of 
information. Obtaining information via peer-reviewed publications requires more 
effort compared to specialists and pharmaceutical representatives. As patients can-
not observe the effort expended, there is a potential for moral hazard in terms of 
reduced effort and thus an increased reliance on pharmaceutical representatives. 
Clinical evidence is often uncertain and not always directly applicable to current 
practice, which can lead to following ‘norm’ prescribing behaviour and persistent 
prescribing when combined with risk-aversion. ConClusions: Rogers’s theory 
only partially explains drug adoption. An expanded framework regarding drug adop-
tion is proposed, incorporating agency relationships, moral hazard, uncertainty 
and risk-aversion.
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objeCtives: Medical nutrition is dedicated to patients with some nutritional defi-
ciencies or inability to eat normally. When used on top of normal diet in patients 
or in Crohn’s disease, medical nutrition can improve patient’s recovery or have a 
therapeutic effect. Although efficacy studies of medical nutrition exist, it is unclear 
regarding health economic analysis. This research assessed the current health eco-
nomic evidence published on medical nutrition. Methods: A systematic literature 
search was performed using PubMed, the Health Technology Assessment Database, 
and the NHS Economic Evaluation Database. For selected articles, the clinical back-
ground and basis of the analysis, health economic design and results were extracted. 
Finally for health economic modeling studies, the Drummond checklist was applied 
to validate their quality; whereas for systematic reviews the AMSTAR checklist 
was used. Results: Fifty-three articles were identified and obtained via PubMed. 
Among them, 32 articles have been included in a thorough data extraction proce-
dure. Among these articles, only few health economic models have been found: Most 
of the articles were modelling analyses and economic trials. Overall only 8 health 
economic models were validated applying the Drummond checklist. Anyhow, most 
included models have been carried out with a quite high quality standard even 
though some areas were identified for further improvement. Within the two iden-
tified reviews of health economic studies one review achieved the highest quality 
scores applying the AMSTAR checklist. ConClusions: Reasons for finding only few 
modeling studies but quite a large number of clinical trials with health economic 
endpoints might have different reasons. Until recently, health economics wasn’t 
required in reimbursement or coverage decisions for medical nutrition interven-
tions; and there might be specificities of medical nutrition which might not allow 
easy modeling. Further research is warranted to understand the specifics of medical 
nutrition and its applicability for health economic modelling.
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objeCtives: Electronic medical records (EMRs) in hospitals are potentially ben-
eficial for quality and safety of care, but diffuse slowly. Many of the barriers and 
facilitators of the adoption of EMRs are identified, but the relative importance of 
these factors is still undetermined. This paper quantifies the relative importance 
of known barriers and facilitators of EMR, experienced by the users (i.e., nurses and 
physicians in hospitals). Methods: A d-efficiently designed discrete choice experi-
ment (DCE) was conducted among physicians and nurses. Participants answered ten 
choice sets containing two scenarios. Each scenario included attributes that were 
based on previously identified barriers in the literature and the model of the Unified 
Theory of Acceptance and Use of Technology (UTAUT), namely : data entry hardware, 
technical support, supervisor attitude, performance feedback, flexibility of interface 
and decision support. Panel Mixed Multinomial Logit analysis was used to determine 
the relative importance of the attributes. Results: Data on 148 nurses and 150 phy-
sicians showed that high flexibility of the interface was the most important factor 
